Anthracycline derivatives belong among the most effective antineoplastic drugs but their therapeutic use is limited by their side effects--a dose-related cardiotoxicity. The influence of repeated i.v. administration (once weekly, max. 10 weeks) of new antineoplastic agents--dimethoxybenfluron (DMB) (3,9-dimethoxybenfluron hydrochloride, C23H24O4NCl, M.w. 413.9, Institute of Experimental Biopharmaceutics, Czech Academy of Sciences, Hradec Králové, Czech Republic; 12 or 24 mg base/kg) and Oracin (6-[2-(2-hydroxyethyl)aminoethyl]-5,11-dioxo-5,6-dihydro-11H- indeno[1,2c]isoquinoline hydrochloride), C20H19N2O3Cl, M.w. 370.84, Research Institute for Pharmacy and Biochemistry, Prague, Czech Republic; 5 or 10 mg/kg) on cardiovascular, biochemical, haematological and histological parameters were studied in rabbits in vivo. Data obtained in these groups were compared with the group with experimentally induced cardiomyopathy (daunorubicin 50 mg/m2 i.v.) and with the control group (saline 1 ml/kg). Only mild and mostly no significant changes of the cardiovascular parameters (DMB 12 group: PEP:LVET ratio--0.408-0.502, LV dP/dtmax.--1337.0 kPa/s; DMB 24 group: PEP:LVET ratio--0.407-0.433, LV dP/dtmax.--1438.2 kPa/s), biochemical parameters (decrease in natrium, ALP and increase in glucose, GPX and GSH levels) and haematological parameters (increase in erythrocytes and decrease in leukocytes after the larger dose of the drug) were found in the dimethoxybenfluron groups. Repeated administration of the lower dose of Oracin induced only mild and mostly no significant changes of parameters (PEP:LVET ratio--0.393-0.475, LV dP/dtmax.--1092.4 kPa/s) in comparison with the control group. Though significant in some intervals, only a mild oscillation of the PEP:LVET ratio (0.368-0.446), decrease in LV dP/dtmax. (991.2 kPa/s) and--in comparison with control group--significantly higher blood pressure and lower heart rate were found after the higher dose of Oracin. In the most of haematological and biochemical parameters (with the exception of chlorides, protein and albumin levels) no significant changes were present. Histological examination of the heart revealed normal structure of the myocardium including minute changes of myocardium following administration of antineoplastic agents in all groups. Administration of new antineoplastic agents induced mostly mild changes of the followed-up parameters (PEP:LVET ratio, LV dP/dtmax., heart rate, levels of cardiac troponin T, survival of animals, haematological and biochemical parameters); the values of parameters were mostly significantly different from those in rabbits with daunorubicin-induced cardiomyopathy. On the basis of our results it is possible to conclude that the administration of dimethoxybenflurone and Oracin did not induce signs of cardiotoxicity in rabbits in vivo. This observation is considered to be important from the viewpoint of possible further clinical use of these new antineoplastic agents.

Ustav farmakologie Univerzita Karlova Praha Lékarská fakulta v Hradci Králové

Effects of new antineoplastic agents (dimethoxybenflurone and Oracin) on the cardiovascular system and other parameters in the rabbit in vivo

000      

00000naa a2200000 a 4500

001      

bmc15011958

003      

CZ-PrNML

005      

20150903093211.0

007      

ta

008      

150401s2000 xr f 000 0|cze||

009      

AR

035    __

$a (PubMed)11413675

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a cze

044    __

$a xr

100    1_

$a Macháčková, Jarmila $u Ustav farmakologie, Univerzita Karlova v Praze, Lékarská fakulta v Hradci Králové. machackovaj@lfhk.cuni.cz $7 xx0139265

245    10

$a Účinky nových antineoplastických látek (Dimethoxybenfluronu and Oracinu) na kardiovaskulární systém / $c J. Machácková, V. Gersl, M. Adamcová, Y. Mazurová, R. Hrdina, M. Mĕlka, M. Nobilis,

246    31

$a Effects of new antineoplastic agents (dimethoxybenflurone and Oracin) on the cardiovascular system and other parameters in the rabbit in vivo

520    9_

$a Anthracycline derivatives belong among the most effective antineoplastic drugs but their therapeutic use is limited by their side effects--a dose-related cardiotoxicity. The influence of repeated i.v. administration (once weekly, max. 10 weeks) of new antineoplastic agents--dimethoxybenfluron (DMB) (3,9-dimethoxybenfluron hydrochloride, C23H24O4NCl, M.w. 413.9, Institute of Experimental Biopharmaceutics, Czech Academy of Sciences, Hradec Králové, Czech Republic; 12 or 24 mg base/kg) and Oracin (6-[2-(2-hydroxyethyl)aminoethyl]-5,11-dioxo-5,6-dihydro-11H- indeno[1,2c]isoquinoline hydrochloride), C20H19N2O3Cl, M.w. 370.84, Research Institute for Pharmacy and Biochemistry, Prague, Czech Republic; 5 or 10 mg/kg) on cardiovascular, biochemical, haematological and histological parameters were studied in rabbits in vivo. Data obtained in these groups were compared with the group with experimentally induced cardiomyopathy (daunorubicin 50 mg/m2 i.v.) and with the control group (saline 1 ml/kg). Only mild and mostly no significant changes of the cardiovascular parameters (DMB 12 group: PEP:LVET ratio--0.408-0.502, LV dP/dtmax.--1337.0 kPa/s; DMB 24 group: PEP:LVET ratio--0.407-0.433, LV dP/dtmax.--1438.2 kPa/s), biochemical parameters (decrease in natrium, ALP and increase in glucose, GPX and GSH levels) and haematological parameters (increase in erythrocytes and decrease in leukocytes after the larger dose of the drug) were found in the dimethoxybenfluron groups. Repeated administration of the lower dose of Oracin induced only mild and mostly no significant changes of parameters (PEP:LVET ratio--0.393-0.475, LV dP/dtmax.--1092.4 kPa/s) in comparison with the control group. Though significant in some intervals, only a mild oscillation of the PEP:LVET ratio (0.368-0.446), decrease in LV dP/dtmax. (991.2 kPa/s) and--in comparison with control group--significantly higher blood pressure and lower heart rate were found after the higher dose of Oracin. In the most of haematological and biochemical parameters (with the exception of chlorides, protein and albumin levels) no significant changes were present. Histological examination of the heart revealed normal structure of the myocardium including minute changes of myocardium following administration of antineoplastic agents in all groups. Administration of new antineoplastic agents induced mostly mild changes of the followed-up parameters (PEP:LVET ratio, LV dP/dtmax., heart rate, levels of cardiac troponin T, survival of animals, haematological and biochemical parameters); the values of parameters were mostly significantly different from those in rabbits with daunorubicin-induced cardiomyopathy. On the basis of our results it is possible to conclude that the administration of dimethoxybenflurone and Oracin did not induce signs of cardiotoxicity in rabbits in vivo. This observation is considered to be important from the viewpoint of possible further clinical use of these new antineoplastic agents.

650    _2

$a zvířata $7 D000818

650    _2

$a antitumorózní látky $x toxicita $7 D000970

650    _2

$a krevní tlak $x účinky léků $7 D001794

650    _2

$a daunomycin $x toxicita $7 D003630

650    _2

$a ethanolaminy $x toxicita $7 D004983

650    _2

$a fluoreny $x toxicita $7 D005449

650    _2

$a srdce $x účinky léků $7 D006321

650    _2

$a srdeční frekvence $x účinky léků $7 D006339

650    _2

$a hemodynamika $x účinky léků $7 D006439

650    _2

$a isochinoliny $x toxicita $7 D007546

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a myokard $x metabolismus $x patologie $7 D009206

650    _2

$a králíci $7 D011817

650    _2

$a funkce levé komory srdeční $x účinky léků $7 D016277

655    _2

$a anglický abstrakt $7 D004740

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Geršl, Vladimír, $d 1946-2015 $7 nlk19990073168

700    1_

$a Adamcová, Michaela, $d 1964- $7 xx0064762

700    1_

$a Mazurová, Yvona, $d 1951- $7 xx0054511

700    1_

$a Hrdina, Radomír $7 xx0077249

700    1_

$a Mělka, Milan, $d 1937-2011 $7 jk01081159

700    1_

$a Nobilis, Milan $7 xx0079581

773    0_

$w MED00011344 $t Acta medica (Hradec Králové). Supplementum $x 1211-247X $g Roč. 43, č. 2 (2000), s. 119-138

856    41

$u https://pubmed.ncbi.nlm.nih.gov/11413675 $y Pubmed

910    __

$a ABA008 $b A 3077 $c sign $y 4 $z 0

990    __

$a 20150401 $b ABA008

991    __

$a 20150903093332 $b ABA008

999    __

$a ok $b bmc $g 1069439 $s 894804

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2000 $b 43 $c 2 $d 119-138 $i 1211-247X $m Acta medica. Supplementum $n Acta med., Suppl. $x MED00011344

LZP    __

$a Pubmed-20150401